Antitumor and antimetastatic effect of warfarin and heparins.
about
Can heparins stimulate bone cancer stem cells and interfere with tumorigenesis?The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trialsPlatelets promote tumor growth and metastasis via direct interaction between Aggrus/podoplanin and CLEC-2.Effect of non-anticoagulant N-desulfated heparin on expression of vascular endothelial growth factor, angiogenesis and metastasis of orthotopic implantation of human gastric carcinoma.Characterization of anticoagulant heparinoids by immunoprofiling.Impact of venous thromboembolism and anticoagulation on cancer and cancer survivalA novel blood tool of cancer prognosis in esophageal squamous cell carcinoma: the Fibrinogen/Albumin RatioUnfractionated heparin: multitargeted therapy for delayed neurological deficits induced by subarachnoid hemorrhage.The effect of therapeutic anticoagulation on overall survival in men receiving first-line docetaxel chemotherapy for metastatic castration-resistant prostate cancer.Clinical use of the low-molecular-weight heparins in cancer patients: focus on the improved patient outcomes.A network model for angiogenesis in ovarian cancer.Warfarin glycosylation invokes a switch from anticoagulant to anticancer activity.Preoperative Plasma Fibrinogen Level Represents an Independent Prognostic Factor in a Chinese Cohort of Patients with Upper Tract Urothelial Carcinoma.Low-molecular-weight heparins and angiogenesis.Relationships of coagulation factor XIII activity with cell-type and stage of non-small cell lung cancer.Cancer, clots and consensus: new understanding of an old problem.Thromboembolic disease in cancer patients.Coagulation and metastasis: what does the experimental literature tell us?Cancer and thrombosis: back to the future renewed interest in an old problem.Warfarin use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.The effect of warfarin therapy on breast, colorectal, lung, and prostate cancer survival: a population-based cohort study using the Clinical Practice Research Datalink.Thrombin promotes epithelial ovarian cancer cell invasion by inducing epithelial-mesenchymal transition.Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer.Risk of prostate cancer death in long-term users of warfarin: a population-based case-control study.Sublingual functional capillary rarefaction in chronic heart failure.Association of Warfarin Use With Lower Overall Cancer Incidence Among Patients Older Than 50 Years.Haemostasis and innate immunity - a complementary relationship: A review of the intricate relationship between coagulation and complement pathways.Oral warfarin affects some aspects of systemic immunomodulation with topical dinitrochlorobenzene (DNCB) in rats.Oral warfarin affects peripheral blood leukocyte IL-6 and TNFα production in rats.Glycosaminoglycan mimicry by COAM reduces melanoma growth through chemokine induction and function.Galbanic acid isolated from Ferula assafoetida exerts in vivo anti-tumor activity in association with anti-angiogenesis and anti-proliferation.The role of blood in early endometrial-peritoneal interactions in a syngeneic mouse model of endometriosis.Antitumor effects of nadroparin combined with radiotherapy in Lewis lung cancer models
P2860
Q26852760-EE1B4536-8EEF-4EBA-92B6-85DAB2CCFFCFQ28296482-0C7A8772-BCC8-473F-974D-5921FA230C7EQ31133789-88FEC7F3-77D6-46B0-955F-F16514E49EB2Q33269554-A12ECB81-1931-4132-AE94-05BD9D13CE02Q33376879-2CAB4B0E-2F5E-4C95-87FB-BC7DA8AAF719Q33561203-035303F8-8FA2-4CB2-B3D1-B33C7608E3B2Q33702344-7CCE5C55-C25D-401E-A075-34899F08BDC0Q34448852-760A8C99-4869-4BDC-8F3F-FBE9BBE5B57FQ35095964-EBAE63DA-7CF0-4A06-90BB-8F98203E17F1Q35368813-30EA6132-C3F8-441C-9D3D-614B8D58A1B0Q35534413-0A7F472D-3950-48D6-871F-1ECAE027BB48Q35552971-2476B2D3-162A-447C-A16D-21D7C2C55E39Q35940860-049BE1E9-287A-4F31-B708-ABE75265D907Q36414904-D18B2522-DB19-4F81-AAF0-0FC688946235Q37259580-CDC21E8B-23A5-4682-91C7-7169B5168115Q37393386-B366861B-1E27-4737-BE66-B2051091AF30Q38083556-807EF747-7A27-4F9E-BF66-A41B10D74A07Q38108356-949EDA13-55E1-4F43-91E5-8DC99D046FD6Q39975745-B5D0EF85-5982-4CC3-89DF-77A5860E1C35Q40501806-96084D17-57EB-438D-B97B-28B8BC99E212Q41656424-7B916D22-47CC-40AD-8258-7123BB63974EQ41834364-0439B6CA-537D-4C46-B283-B638759559BAQ44018149-BBF640C9-72EB-42AA-9A92-63E7C4D0D129Q44665233-51134DB0-9B8E-48AE-B4F5-69501F1C3431Q47227141-731790EA-B981-41C8-A68B-7338A9F6BAFDQ47586700-B19D6DF8-4A89-40D9-AF01-6CE7176C5E8DQ48371887-4EF0C1E9-F341-45EE-8971-ED7CCA2EC33AQ51210417-FC057A83-9CD1-432D-8051-28D7357389DAQ51556684-C27A0FCC-7D3B-4D33-A9FF-87FFE232A6B9Q54346279-55E80F76-8D11-4D5C-AB93-DC8CF21C63CCQ54633871-D461B5BC-0479-4AC4-9657-866943E72AD7Q55091108-F262510E-3554-42ED-A0A2-505FE87CC304Q58705958-4F37CE0C-90F3-4052-8DBD-ED57FF9B7502
P2860
Antitumor and antimetastatic effect of warfarin and heparins.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Antitumor and antimetastatic effect of warfarin and heparins.
@ast
Antitumor and antimetastatic effect of warfarin and heparins.
@en
type
label
Antitumor and antimetastatic effect of warfarin and heparins.
@ast
Antitumor and antimetastatic effect of warfarin and heparins.
@en
prefLabel
Antitumor and antimetastatic effect of warfarin and heparins.
@ast
Antitumor and antimetastatic effect of warfarin and heparins.
@en
P1476
Antitumor and antimetastatic effect of warfarin and heparins
@en
P2093
Josef Kovarík
P304
P356
10.1016/J.BIOPHA.2003.11.007
P577
2004-05-01T00:00:00Z